SLC5A5 and hepatocellular carcinoma: To quantify HIF-NIS-MSC-mediated tumoral radioiodide accumulation in the subcutaneous and intrahepatic HCC tumors, ex vivo123I-biodistribution analysis was performed 4 h after radioiodide injection by measuring the 123I uptake in individual tissues.